Adi Mor is the founder of Chemomab. Chemomab has raised $56M in total funding. Latest round: Series B. Backed by OrbiMed, HBM Partners, Sphera.
Adi Mor is the CEO, CSO, and co-founder of Chemomab, a company she co-founded in 2011. Chemomab focuses on developing innovative therapeutics for fibro-inflammatory diseases. Mor has extensive experience in immunology, particularly in autoimmune and inflammatory conditions, and has been instrumental in designing and patenting novel monoclonal antibodies.
Full founder directory · Investor directory · Company funding database · Fundraising library